Annual Drug Patent Expirations for KYPROLIS
Kyprolis is a drug marketed by Onyx Pharms Amgen and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for KYPROLIS.
This drug has one hundred and ninety-one patent family members in forty-two countries.
The generic ingredient in KYPROLIS is carfilzomib. One supplier is listed for this compound. Additional details are available on the carfilzomib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
